Stay updated on SBRT ± Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.

Latest updates to the SBRT ± Nivolumab in NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3. This update appears to modify internal versioning information and does not change displayed content.SummaryDifference0.1%

- Check25 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. There are no observable changes to study details or core content.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded Revision: v3.4.2 and removed the older notices, including the lapse in government funding message and Revision: v3.4.1.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a government funding lapse notice warning of possible delays in updating information and directing users to cc.nih.gov and opm.gov for status. Updated the site revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check68 days agoChange DetectedUI and metadata refinements were added (glossary toggle, updated last update labels, and version information), while the core study data and eligibility details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check82 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; there are no changes to study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to SBRT ± Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.